The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
Abstract
Huntington's Disease (HD) is characterized primarily by neuropathological changes in the striatum, including loss of medium‐spiny neurons, nuclear inclusions of the huntingtin protein, gliosis, and abnormally high iron levels. Information about how these conditions interact, or about the temporal order in which they appear, is lacking. This study investigated if, and when, iron‐related changes occur in the R6/2 transgenic mouse model of HD and compared the results with those from HD patients. Relative to wild‐type mice, R6/2 mice had increased immunostaining for ferritin, an iron storage protein, in the striatum beginning at 2–4 weeks postnatal and in cortex and hippocampus starting at 5–7 weeks. The ferritin staining was found primarily in microglia, and became more pronounced as the mice matured. Ferritin‐labeled microglia in R6/2 mice appeared dystrophic in that they had thick, twisted processes with cytoplasmic breaks; some of these cells also contained the mutant huntingtin protein. Brains from HD patients (Vonsattel grades 0–4) also had increased numbers of ferritin‐containing microglia, some of which were dystrophic. The cells were positive for Perl's stain, indicating that they contained abnormally high levels of iron. These results provide the first evidence that perturbations to iron metabolism in HD are predominately associated with microglia and occur early enough to be important contributors to HD progression. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts
Halliwell, B., & Gutteridge, J. M. C. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90305-x · Cited by 2,038
Microglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Kasai, H. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00035-5 · Cited by 1,139
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein
Uversky, V. N., Li, J., & Fink, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105343200 · Cited by 1,103
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872 · cited 2×
“cule 1 (IBA1), which is expressed specifically in macrophages/microglia (Imai et al., 1996).”
BackgroundMethodInfluentialThe roles of iron in health and disease
Lieu, P. T., Heiskala, M., Peterson, P. A., & Yang, Y. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00006-6 · Cited by 804
Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709
Dystrophic microglia in the aging human brain
Streit, W. J., Sammons, N. W., Kuhns, A. J., & Sparks, D. L. (2004) · Glia · doi:10.1002/glia.10319 · Cited by 705
Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 680
I RON S TATUS AND N EURAL F UNCTIONING
Beard, J. L., & Connor, J. R. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.020102.075739 · Cited by 669
Microglia in health and disease
Kim, S. U., & de Vellis, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20562 · Cited by 663
Normal huntingtin function: an alternative approach to Huntington's disease
Cattaneo, E., Zuccato, C., & Tartari, M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1806 · Cited by 657
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain
Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J. P., & Difiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 540
Huntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and Autophagy
Kegel, K. B., Kim, M., Sapp, E., McIntyre, C., Castaño, J. G., Aronin, N., & DiFiglia, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07268.2000 · Cited by 533
Widespread expression of Huntington's disease gene (IT15) protein product
Sharp, A. H., Loev, S. J., Schilling, G., Li, S.-H., Li, X.-J., Bao, J., Wagster, M. V., Kotzuk, J. A., Steiner, J. P., Lo, A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90345-3 · Cited by 513
Oxidative stress in Huntington’s disease
Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 508
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J.-Y., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S.-H., & Li, X.-J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 477
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
Connor, J. R., Menzies, S. L., St. Martin, S. M., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310111 · Cited by 467
Microglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · cited 4×
“, 2007) and they correlate with the number of CAG repeats and the severity of the motor component of the disease (Pavese et al., 2006).”
BackgroundInfluentialCell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., & Wisniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
Aisen, P., Wessling-Resnick, M., & Leibold, E. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80033-7 · Cited by 427
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues
Strong, T. V., Tagle, D. A., Valdes, J. M., Elmer, L. W., Boehm, K., Swaroop, M., Kaatz, K. W., Collins, F. S., & Albin, R. L. (1993) · Nature Genetics · doi:10.1038/ng1193-259 · Cited by 416
Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages
Allen, W. E., Jones, G. E., Pollard, J. W., & Ridley, A. J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.6.707 · Cited by 409
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Microglial senescence: does the brain's immune system have an expiration date?
Streit, W. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.001 · Cited by 397
Iron regulates ferritin mRNA translation through a segment of its 5′-untranslated region.
Aziz, N., & Munro, H. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8478 · Cited by 368
Brain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P., Altshuler, L. L., Carter, M., Huang, D., Edwards, N., & Mintz, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 341
Control of glial immune function by neurons
Neumann, H. (2001) · Glia · doi:10.1002/glia.1108 · Cited by 319
Dexter, D. T., Jenner, P., Schapira, A. H. V., Marsden, C. D., & The Royal Kings and Queens Parkinson's Disease Research Group (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292
Ponka, P. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69002.x · Cited by 274
Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia
Grundke-Iqbal, I., Fleming, J., Tung, Y. C., Lassmann, H., Iqbal, K., & Joshi, J. G. (1990) · Acta Neuropathologica · doi:10.1007/bf00334497 · Cited by 253
Dizdaroglu, M., Rao, G., Halliwell, B., & Gajewski, E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90366-q · Cited by 244
Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus
Myers, R. H., Vonsattel, J. P., Paskevich, P. A., Kiely, D. K., Stevens, T. J., Cupples, L. A., Richardson, E. P., & Bird, E. D. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00005 · Cited by 239
Role of Iron in Neurodegenerative Disorders
Berg, D., & Youdim, M. B. H. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245461.90406.ad · Cited by 226
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles
Hilditch-Maguire, P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2789 · Cited by 226
Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies
Borrell-Pagès, M., Zala, D., Humbert, S., & Saudou, F. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6242-0 · Cited by 222
G Proteins and Small GTPases: Distant Relatives Keep in Touch
Hall, A. (1998) · Science · doi:10.1126/science.280.5372.2074 · Cited by 217
Bartzokis, G., & Tishler, T. A. (2000) · PubMed · Cited by 197
Nguyen, T., Hamby, A., & Massa, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502177102 · Cited by 194
Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
BARTZOKIS, G., TISHLER, T. A., SHIN, I., LU, P. H., & CUMMINGS, J. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.019 · Cited by 186
Theta Stimulation Polymerizes Actin in Dendritic Spines of Hippocampus
Lin, B., Kramár, E. A., Bi, X., Brucher, F. A., Gall, C. M., & Lynch, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4283-04.2005 · Cited by 184
Self-citationIncreased basal ganglia iron levels in Huntington disease
Bartzokis, G., Cummings, J., Perlman, S., Hance, D. B., & Mintz, J. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.569 · Cited by 183
MR evaluation of age-related increase of brain iron in young adult and older normal males
Bartzokis, G., Beckson, M., Hance, D. B., Marx, P., Foster, J. A., & Marder, S. R. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00234-2 · Cited by 181
Isoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179
Iron regulation in the brain: Histochemical, biochemical, and molecular considerations
Connor, J. R., & Benkovic, S. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320710 · Cited by 176
Kanazawa, H., Ohsawa, K., Sasaki, Y., Kohsaka, S., & Imai, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109218200 · Cited by 172
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E. J., Wheeler, V. C., Woodman, B., & Schwarcz, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166
Shi, T., Knaapen, A. M., Begerow, J., Birmili, W., Borm, P. J. A., & Schins, R. P. F. (2003) · Occupational and Environmental Medicine · doi:10.1136/oem.60.5.315 · Cited by 158
Chen, J. C., Hardy, P., Kucharczyk, W., Clauberg, M., Joshi, J. G., Vourlas, A., Dhar, M. S., & Henkelman, R. M. (1993) · PubMed Central · Cited by 156
Ferritin immunohistochemistry as a marker for microglia
Kaneko, Y., Kitamoto, T., Tateishi, J., & Yamaguchi, K. (1989) · Acta Neuropathologica · doi:10.1007/bf00294369 · Cited by 153
In Vitro Studies of Ferritin Iron Release and Neurotoxicity
Double, K. L., Maywald, M., Schmittel, M., Riederer, P. F., & Gerlach, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062492.x · Cited by 152
Imaging microglial activation in Huntington's disease
Tai, Y., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. P. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.029 · Cited by 143
In vivo MR evaluation of age-related increases in brain iron.
Bartzokis, G., Mintz, J., Sultzer, D. L., Marx, P., Herzberg, J., Phelan, C., & Marder, S. R. (1994) · PubMed Central · Cited by 140
Depletion of wild‐type huntingtin in mouse models of neurologic diseases
Zhang, Y., Li, M.-W., Drozda, M., Chen, M.-H., Ren, S.-J., Sanchez, R. O. M., Leavitt, B., Cattaneo, E., Ferrante, R., Hayden, M. R., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01980.x · Cited by 135
Meade, C. A., Deng, Y., Fusco, F. R., Mar, N. D., Hersch, S. M., Goldowitz, D., & Reiner, A. J. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10295 · Cited by 125
Does cellular iron dysregulation play a causative role in Parkinson’s disease?
Kaur, D., & Andersen, J. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.003 · Cited by 123
Iron, neuroinflammation, and Alzheimer's disease
Ong, W.-Y., & Farooqui, A. A. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8211 · Cited by 119
Figueredo-Cardenas, G., Harris, C. L., Anderson, K. D., & Reiner, A. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6724 · Cited by 99
Iron in neurodegenerative disorders
Berg, D., Becker, G., Riederer, P. F., & Rieß, O. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045444 · Cited by 98
Poirier, J., Donaldson, J., & Barbeau, A. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91639-0 · Cited by 94
Genetic contributions to Parkinson's disease
Huang, Y. M., Cheung, L., Rowe, D. B., & Halliday, G. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.007 · Cited by 91
Focht, S. J., Snyder, B. S., Beard, J. L., van Gelder, W., Williams, L. R., & Connor, J. R. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00607-0 · Cited by 86
Oxidation-induced ferritin turnover in microglial cells: role of proteasome
Mehlhase, J., Sandig, G., Pantopoulos, K., & Grune, T. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.025 · Cited by 84
Activated microglia cause superoxide-mediated release of iron from ferritin
Yoshida, T., Tanaka, Μ., Sotomatsu, A., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11490-n · Cited by 79
Microglia density decreases with age in a mouse model of Huntington's disease
Ma, L., Morton, A. J., & Nicholson, L. F. B. (2003) · Glia · doi:10.1002/glia.10261 · Cited by 74
Huntingtin inclusion bodies are iron‐dependent centers of oxidative events
Firdaus, W. J. J., Wyttenbach, A., Giuliano, P., Kretz‐Remy, C., Currie, R. W., & Arrigo, A. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05537.x · Cited by 71
Hwang, I. K., Yoo, K., Kim, D. W., Choi, S. Y., Kang, T., Kim, Y., & Won, M. H. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9101-3 · Cited by 70
Amyloid-β Metal Interaction and Metal Chelation
Cuajungco, M. P., Frederickson, C. J., & Bush, A. I. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_12 · Cited by 68
Hayes, A., Thaker, U., Iwatsubo, T., Pickering-Brown, S. M., & Mann, D. M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00888-1 · Cited by 68
Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics.
Wierzba‐Bobrowicz, T., Lewandowska, E., Kosno-Kruszewska, E., Lechowicz, W., Pasennik, E., & Schmidt-Sidor, B. (2004) · PubMed · Cited by 65
The Ubiquitin-Proteasome System in Huntington’s Disease
Valera, A., Dı́az-Hernández, M., Hernández, F., Ortega, Z., & Lucas, J. J. (2005) · The Neuroscientist · doi:10.1177/1073858405280639 · Cited by 55
Ascorbic acid and iron metabolism: alterations in lysosomal function
Hoffman, K., Yanelli, K., & Bridges, K. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1188s · Cited by 49
Activated microglia cause iron-dependent lipid peroxidation in the presence of ferritin
Yoshida, T., Tanaka, M., Sotomatsu, A., Hirai, S., & Okamoto, K. (1998) · Neuroreport · doi:10.1097/00001756-199806220-00003 · Cited by 42
Polazzi, E., & Contestabile, A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.005 · Cited by 40
Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain
Hansen, T. M., Nielsen, H., Bernth, N., & Moos, T. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00011-x · Cited by 38
Kaur, C., & Ling, E. A. (1995) · PubMed Central · Cited by 35
Swaiman, K. F., & Machen, V. L. (1985) · Neurochemical Research · doi:10.1007/bf00988605 · Cited by 35
Serum ferritin deficiency in Huntington's disease patients
Bonilla, E., Estévez, J., Suárez, H., et al. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90711-2 · Cited by 24
Serum iron, total iron binding capacity and ferritin in early huntington disease patients
Morrison, P. J., & Nevin, N. C. (1994) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02943258 · Cited by 15
Impairment of energy metabolism and excitotoxic cell death in Huntington disease.
Young, A. B. (1997) · PubMed · Cited by 8
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9861(19981012)400:1
Cited by
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Microglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 870
Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727
Microglia: biology and pathology
Graeber, M. B., & Streit, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 725
Metadata
- Authors
- Simmons, D. A., Casale, M., Alcon, B., Pham, N., Narayan, N., & Lynch, G.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2007-06-05
- Volume
- 55
- Issue
- 10
- Pages
- 1074-1084
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2009110155
- Cited by
- 277
- References
- 97
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.